Mkts

Cellectis S.A.

NASDAQ: CLLS
$1.03-0.03 (-2.83%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
1.021.08
52-week range
0.904.75
Today
Open1.06
Previous close1.03
Volume339
Valuation
Market cap73.27M
P/E ratio—
EPS (TTM)-1.44
Income & risk
Dividend / yield—
Beta1.23
Avg volume369.3K
Discussion

CLLS News

Stories mentioning CLLS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ2 '23Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)
Earnings Per Share (Basic)(0.20)
Earnings Per Share (Diluted)(0.20)
Weighted Average Shares Outstanding (Basic)
Weighted Average Shares Outstanding (Diluted)

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CLLS

Cellectis S.A. (NASDAQ: CLLS) is a stock listed on the Nasdaq Stock Market under the ticker symbol CLLS. It last traded at $1.03 (Nov 18, 2026, 4:00 PM ET), down 2.8% on the day. That gives Cellectis a market capitalisation of $73.3M.

Over the past 52 weeks CLLS has traded between $0.9000 and $4.75.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…